Reaction Details |
| Report a problem with these data |
Target | LIM domain kinase 2 |
---|
Ligand | BDBM622423 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | In Vitro Assay |
---|
Ki | 10.9±n/a nM |
---|
Citation | ROUTIER, S; BENEDETTI, H; LÉE-MÉHEUST, B; BONNET, P; PLÉ, K; ACI-SÈCHE, S; RUCHAUD, S; BRAKA, A; CHAMPIRÉ, A; ANDRES, C; VOURC''H, P 4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-3,6-DIHYDROPYRIDINE-1-(2H)-CARBOXAMIDE DERIVATIVES AS LIMK AND/OR ROCK KINASES INHIBITORS FOR USE IN THE TREATMENT OF CANCER US Patent US20230312576 Publication Date 10/5/2023 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
LIM domain kinase 2 |
---|
Name: | LIM domain kinase 2 |
Synonyms: | LIMK2 | LIMK2_HUMAN |
Type: | PROTEIN |
Mol. Mass.: | 72238.81 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_1514398 |
Residue: | 638 |
Sequence: | MSALAGEDVWRCPGCGDHIAPSQIWYRTVNETWHGSCFRCSECQDSLTNWYYEKDGKLYC
PKDYWGKFGEFCHGCSLLMTGPFMVAGEFKYHPECFACMSCKVIIEDGDAYALVQHATLY
CGKCHNEVVLAPMFERLSTESVQEQLPYSVTLISMPATTEGRRGFSVSVESACSNYATTV
QVKEVNRMHISPNNRNAIHPGDRILEINGTPVRTLRVEEVEDAISQTSQTLQLLIEHDPV
SQRLDQLRLEARLAPHMQNAGHPHALSTLDTKENLEGTLRRRSLRRSNSISKSPGPSSPK
EPLLFSRDISRSESLRCSSSYSQQIFRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMK
ELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSM
DPFPWQQKVRFAKGIASGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEER
KRAPMEKATTKKRTLRKNDRKKRYTVVGNPYWMAPEMLNGKSYDETVDIFSFGIVLCEII
GQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCRLEPESRPAFSKLEDS
FEALSLYLGELGIPLPAELEELDHTVSMQYGLTRDSPP
|
|
|
BDBM622423 |
---|
n/a |
---|
Name | BDBM622423 |
Synonyms: | US20230312576, Compound 79 |
Type | Small organic molecule |
Emp. Form. | C27H25N5O2 |
Mol. Mass. | 451.5197 |
SMILES | O=C(Nc1cccc(Oc2ccccc2)c1)N1CCC(=CC1)c1ncnc2[nH]cc(C3CC3)c12 |c:21| |
Structure |
|